MicroPort NeuroTech Limited provided preliminary consolidated earnings guidance for the six months ended 30 June 2024. Based on the preliminary assessment of the unaudited consolidated management accounts of the Group and other currently available information for the six months ended 30 June 2024 (the "Reporting Period"), the Group is expected to record a revenue of approximately RMB 400 million to RMB 410 million, representing an increase of approximately 34% to 37% as compared to that of the six months ended 30 June 2023 (the "Prior-year Period").
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 HKD | +0.14% | +2.98% | -40.69% |
07-09 | MicroPort Scientific Forecasts Decline in Net Loss for H1 on Higher Revenue | MT |
07-02 | Microport NeuroTech's Revenue to Rise Up to 37% in H1 | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.69% | 541M | |
+11.75% | 127B | |
+0.97% | 12.35B | |
-18.47% | 7.1B | |
+56.20% | 6.78B | |
+9.27% | 3.47B | |
-15.41% | 2.6B | |
-18.25% | 1.91B | |
-27.00% | 1.62B | |
-37.52% | 1.45B |
- Stock Market
- Equities
- 2172 Stock
- News MicroPort NeuroTech Limited
- MicroPort NeuroTech Limited Provides Preliminary Consolidated Earnings Guidance for the Six Months Ended 30 June 2024